Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cassiopea announces filing for delisting of its registered shares from SIX Swiss Exchange

eqs_en 
0 0 04.02.22
Cassiopea announces filing for delisting of its registered shares from SIX Swiss Exchange
 

Cassiopea S.p.A. / Key word(s): Delisting
Cassiopea announces filing for delisting of its registered shares from SIX Swiss Exchange

04-Feb-2022 / 07:01 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.

Ad hoc announcement pursuant to Art. 53 LR

Lainate, Italy, February 4, 2022: Cassiopea S.p.A. (SIX: SKIN) ('Cassiopea') today announced that it has filed for delisting of its registered shares from SIX Swiss Exchange ('SIX'). Cassiopea has applied for a last trading day on March 4, 2022, which is subject to the approval by SIX.

About Cassiopea
Cassiopea is a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action to address long-standing and essential dermatological conditions, particularly acne, androgenetic alopecia (or AGA) and genital warts. Cassiopea is investing in innovation that is driving scientific advancement in areas that have been largely ignored for decades. The portfolio comprises four unencumbered clinical candidates, for which Cassiopea owns the worldwide rights. The Company's strategy is to leverage this expertise to optimize the commercial potential for its products with commercial partners. For further information on Cassiopea, please visit www.cassiopea.com.

Contact

Cassiopea SpA

Pierpaolo Guzzo, CEO
Tel              +39 02 868 911 24 
E-mail        [email protected]


End of ad hoc announcement
Language: English
Company: Cassiopea S.p.A.
Via Cristoforo Colombo 1
20045 Lainate
Switzerland
E-mail: [email protected]
Internet: https://www.cassiopea.com/
ISIN: IT0005108359
Listed: SIX Swiss Exchange
EQS News ID: 1276604

 
End of Announcement EQS News Service

1276604  04-Feb-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1276604&application_name=news&site_id=sharewise

Cassiopea SpA Stock

€0.010
-


Show more
Like: 0
Share
eqs_en 
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments

Not a member yet? Sign up for free!